Tuberculosis

With health insurance enrollment season in full swing, you may be researching which plan to get—and signing those data disclosure forms. But have you ever wondered how some of that info is used once you sign on the dotted line?

She was supposed to have a simple procedure to fix a small hole in her heart—then learned it was actually the size of an egg and required heart surgery. For American Heart Month, Cat Oyler, Vice President of Global Public Health, Johnson & Johnson, shares her story of recovery—and why she doesn’t want to be called a survivor.

It isn’t just music superstars who attend the annual event taking place in New York City and South Africa this year. Johnson & Johnson’s Chief Scientific Officer, Dr. Paul Stoffels, is on the lineup, too. He shares his personal story of why he’s so dedicated to global public health—and how the company is working to prevent HIV infections through an investigational vaccine.

Johnson & Johnson has been instrumental in helping bring us closer to a TB-free world through its groundbreaking work with multidrug-resistant TB.

Preventative HIV innovations. Better access to oncology care. A mobile messaging service for moms. These are just a few of the initiatives underway—and Chairman and CEO Alex Gorsky sits down for an exclusive interview about all of them.

When the company was first listed on the New York Stock Exchange in 1944, the world was a very different place. Case in point: A quart of milk cost 15 cents!

In recognition of World Health Day on April 7, company leaders explain what #HealthForAll means to them—and how that commitment shapes everything they do on the job.

As the Next Einstein Forum Global Gathering kicks off in Rwanda this week, we look at how Johnson & Johnson is helping nurture scientific progress across the continent.

In just two years, a unique collaboration has had an unprecedented impact in the fight against the national epidemic. In honor of World TB Day on March 24, we traveled to one of its most affected provinces to report on the project’s remarkable results.

Two decades after leaving India, Anil Koul has returned to helm its Institute of Microbial Technology. For Dengue Awareness Month, we caught up with him to learn how he’s hoping to combat this tropical scourge and another disease that kills over a million worldwide.